MedPath

Clinical Trial on Post Covid 19 through Ayurvedic intervention Agastya Haritaki amd Ashwagandha along with Yoga

Phase 3
Conditions
Health Condition 1: -
Registration Number
CTRI/2021/03/031686
Lead Sponsor
CCRAS Ministry Of AYUSH Govt of India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with history of RT-PCR or IgM antibodies for SARS CoV-2 positivity before, not more than 4 weeks but having negative RT-PCR for SARS CoV-2 at the time of screening.

Patients of either sex between 18 to 60 years

Patients ambulatory and willing to provide informed written consent.

Exclusion Criteria

Pregnant, Lactating women, patients with CKD (Chronic Kidney Disease).

Not willing to participate in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in respiratory function San Diego Shortness of Breath Questionnaire SOBQ 6min walk test and PFTTimepoint: One Month
Secondary Outcome Measures
NameTimeMethod
Change in HRCT Chest <br/ ><br>Change in Fatigue score (Modified Fatigue Impact Scale) <br/ ><br>Change in Anxiety score (HADS Score) <br/ ><br>Change in Sleep Quality (Pittsburgh Sleep Quality Index) <br/ ><br>Change in the Quality of Life (COV19-QoL scale).Timepoint: One Month
© Copyright 2025. All Rights Reserved by MedPath